导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -8.45% | 803/1050 |
| 近一周 | -2.24% | 874/1104 |
| 近一月 | -6.32% | 618/1103 |
| 近一季 | -3.31% | 378/1094 |
| 近半年 | -7.04% | 717/1074 |
| 近一年 | -11.04% | 742/1020 |
| 近两年 | 16.46% | 803/926 |
| 近三年 | -1.56% | 693/834 |
| 成立以来 | 201.81% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-6.06% 862/1070 |
-2.36% 739/1101 |
- - |
- - |
| 2025 | 6.62% 862/1065 |
1.39% 692/1014 |
-4.88% 952/1038 |
12.90% 784/1050 |
-2.07% 558/1065 |
| 2024 | 12.65% 227/1011 |
1.24% 249/960 |
-1.42% 402/983 |
18.39% 94/991 |
-4.66% 648/1011 |
| 2023 | -9.93% 329/952 |
3.92% 379/880 |
-6.83% 634/895 |
3.29% 15/915 |
-9.93% 854/952 |
| 2022 | -12.44% 128/867 |
-7.14% 56/773 |
5.72% 478/806 |
-7.95% 141/845 |
-3.12% 582/867 |
| 2021 | 6.40% 283/740 |
1.00% 108/580 |
6.47% 437/659 |
-6.77% 407/704 |
6.13% 176/740 |
| 2020 | 70.37% 144/554 |
-3.55% 250/419 |
24.31% 203/466 |
17.73% 86/517 |
20.71% 113/554 |
| 2019 | 74.15% 21/410 |
35.94% 123/1146 |
1.46% 208/1228 |
11.46% 91/390 |
13.30% 86/410 |
| 2018 | -28.78% 200/349 |
- - |
-0.39% 89/990 |
-10.24% 768/1000 |
-12.91% 719/1080 |
| 2017 | 25.97% 59/285 |
- - |
- - |
- - |
- - |
| 2016 | 0.24% 28/205 |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8665 | 61.36% |
| 招商前沿医疗保健股票C | 0.8313 | 61.04% |
| 招商医药健康产业股票 | 2.7000 | 53.78% |
| 前海开源公共卫生股票A | 0.4844 | 46.12% |
| 广发医药精选股票A | 1.3562 | 44.63% |
| 嘉实医疗保健股票 | 2.6570 | 42.34% |
| 前海开源公共卫生股票C | 0.4741 | 42.24% |
| 广发医药精选股票C | 1.3346 | 40.86% |
| 交银医药创新股票A | 2.9498 | 37.46% |
| 交银医药创新股票C | 3.1324 | 37.26% |
| 建信大安全战略精选股票 VS. 东吴新产业精选股票A(580008) |